Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Multiple VC Mega-Rounds Fund T-Cell, Hearing, IO, Fibrosis Therapies

Mar 07 2020

• By Mandy Jackson

Finance Watch

Related Content

Finance Watch: Investments In Regenerative Therapies Surged In The Second Quarter

Aug 11 2018

Finance Watch: Government Grants Galore And Other New Funding Sources

Oct 04 2018

Inrebic Approval Is A Boost For Myelofibrosis And Celgene's Buyer Bristol

Aug 16 2019

Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule

Jul 16 2018

Novartis Adds To NASH Pipeline By Licensing Pliant’s Integrin Inhibitor

Oct 23 2019

Tizona Lands AbbVie Cancer R&D Deal As New CEO Takes Control

Jan 09 2019

Novartis buys CoStim as big pharmas boost their cancer immunotherapy arsenals

Feb 17 2014

Deal Watch: Pfizer, Biogen Partnership One Of Many As JPM Gets Underway

Jan 13 2020

Troubled Immunocore Reawakens With New $130m Funding

Mar 02 2020

Another Early-Stage VC Win: Pliant Raises $45m For Fibrosis Startup

Feb 18 2016

Israel's Kahr Medical Attracts Investments From Sanofi, Others

Apr 20 2011

Related Companies

Immunocore, Ltd.

Xilio Therapeutics, Inc.

Pliant Therapeutics, Inc.

City of Hope

Novartis AG

Amunix Pharmaceuticals, Inc.

AstraZeneca PLC

KAHR Medical Ltd.

Impact Biomedicines, Inc.

Bristol Myers Squibb Company

Dana-Farber/Harvard Cancer Center

Novartis AG

Tizona Therapeutics, Inc.

AbbVie Inc.

Additional Topics

Financing StartUps and SMEs Business Strategies Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window